Vericel (VCEL) Total Debt (QoQ) (2011 - 2018)
Powered by 
Analysis
Vericel (VCEL) Total Debt (QoQ) (2011 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -8.15% |
| Jun 30, 2018 | -1.85% |
| Mar 31, 2018 | 5.01% |
| Dec 31, 2017 | 62.59% |
| Sep 30, 2017 | 8.35% |
| Jun 30, 2017 | -3.84% |
| Mar 31, 2017 | 587.18% |
| Dec 31, 2016 | -74.98% |
| Sep 30, 2016 | 11,950.00% |
| Jun 30, 2016 | -16.13% |
| Mar 31, 2016 | -92.51% |
| Dec 31, 2015 | 922.22% |
| Sep 30, 2015 | -10.99% |
| Jun 30, 2015 | -9.00% |
| Mar 31, 2015 | -78.12% |
| Dec 31, 2014 | -73.35% |
| Sep 30, 2014 | -65.70% |
| Jun 30, 2014 | 249,900.00% |
| Mar 31, 2014 | -83.33% |
| Dec 31, 2013 | 20.00% |